Volume 72, Issue 4 pp. 569-573
Original Article: Gastroenterology: Inflammatory Bowel Disease

Moderate-to-severe Endoscopic Inflammation is Frequent After Clinical Remission in Pediatric Ulcerative Colitis

Chen Sarbagili-Shabat

Chen Sarbagili-Shabat

PIBD Research center, Paediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon

The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv

Search for more papers by this author
Dror Weiner

Dror Weiner

PIBD Research center, Paediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon

Search for more papers by this author
Joram Wardi

Joram Wardi

Department of Gastroenterology, The E. Wolfson Medical Center, Holon, Israel

Search for more papers by this author
Lee Abramas

Lee Abramas

PIBD Research center, Paediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon

Search for more papers by this author
Michal Yaakov

Michal Yaakov

PIBD Research center, Paediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon

Search for more papers by this author
Arie Levine

Corresponding Author

Arie Levine

PIBD Research center, Paediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon

The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv

Address correspondence and reprint requests to Arie Levine, Paediatric Gastroenterology and Nutrition Unit, Wolfson Medical Center, Holon, Israel (e-mail: [email protected]).Search for more papers by this author
First published: 16 December 2020
Citations: 7

Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal's Web site (www.jpgn.org).

A.L. has IP or received travel grants, speakers’ honoraria, research grants from Nestle, Janssen, AbbVie, Megapharm, and Takeda.

ABSTRACT

Objectives:

Pediatric ulcerative colitis (UC) is characterized by low sustained remission rates and frequent extension of disease even if clinical remission is obtained with therapy. Moderate-to-severe endoscopic activity is a risk factor for relapse while prospective evidence regarding early mucosal healing or persistence of inflammation after remission in children is not available. Our aim was to evaluate if significant inflammation is common after clinical remission and could explain the high relapse rate in pediatric UC.

Methods:

Pediatric UC patients with clinical remission, defined as pediatric UC activity index (PUCAI) scores <10, were prospectively assessed for mucosal healing by endoscopy 3 to 5 months after remission was documented. Mayo score was assessed for each segment by a blinded adult gastroenterologist using central reading. Symptomatic patients before sigmoidoscopy were excluded. Sustained remission was assessed retrospectively at 18 months follow-up.

Results:

Forty-two children were screened, 28 children in continuous clinical remission at time of sigmoidoscopy were included. Mayo 0 was present in 12/28 (42.86%), Mayo 1 in 2/28 (7.1%) and Mayo 2 to 3 in 14/28 (50.0%) endoscopies. Among 23 patients with follow-up through 18 months, remission was sustained in 6/12 (50.0%) with Mayo score 0 to 1 versus 2/11 (18.18%) of patients with Mayo 2 and 3.

Conclusions:

Over 50% of children assessed for mucosal healing 3 to 5 months after clinical remission is obtained, have endoscopic disease, primarily moderate-to-severe Mayo 2 to 3 inflammation, which was associated with lower sustained remission.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.